Jaya Goyal

2.5k total citations
38 papers, 1.4k citations indexed

About

Jaya Goyal is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Jaya Goyal has authored 38 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 8 papers in Pathology and Forensic Medicine and 8 papers in Immunology. Recurrent topics in Jaya Goyal's work include Muscle Physiology and Disorders (7 papers), Multiple Sclerosis Research Studies (7 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Jaya Goyal is often cited by papers focused on Muscle Physiology and Disorders (7 papers), Multiple Sclerosis Research Studies (7 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Jaya Goyal collaborates with scholars based in United States, United Kingdom and Switzerland. Jaya Goyal's co-authors include David E. Wazer, John M. Cowan, Sang Woo Lee, Karen Smith, Vimla Band, Norm Allaire, Tatiana Plavina, Neil C. Josephson, Kyungmin Hahm and Dan Jun Li and has published in prestigious journals such as Journal of Biological Chemistry, Blood and PLoS ONE.

In The Last Decade

Jaya Goyal

36 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jaya Goyal United States 15 438 361 275 264 224 38 1.4k
Monica Hermanson Sweden 12 635 1.4× 211 0.6× 447 1.6× 307 1.2× 135 0.6× 15 1.2k
Charles D. Bangs United States 19 605 1.4× 177 0.5× 228 0.8× 580 2.2× 264 1.2× 44 1.6k
Samantha J. Busfield Australia 21 578 1.3× 638 1.8× 190 0.7× 625 2.4× 90 0.4× 41 1.9k
Charlotte Rorsman Sweden 10 668 1.5× 188 0.5× 104 0.4× 182 0.7× 53 0.2× 15 1.1k
D. Wade Clapp United States 25 799 1.8× 254 0.7× 265 1.0× 337 1.3× 526 2.3× 49 2.5k
Carol M. Sullivan United States 6 491 1.1× 284 0.8× 246 0.9× 183 0.7× 102 0.5× 7 982
Lucia Zanetta Italy 12 1.1k 2.5× 323 0.9× 177 0.6× 269 1.0× 137 0.6× 15 1.9k
Karin Gustafsson United States 15 673 1.5× 347 1.0× 255 0.9× 426 1.6× 146 0.7× 34 1.6k
Lawrence E. Goldfinger United States 22 1.1k 2.4× 381 1.1× 117 0.4× 359 1.4× 98 0.4× 55 2.2k
Abel Sánchez‐Aguilera Spain 21 1.0k 2.3× 564 1.6× 564 2.1× 646 2.4× 97 0.4× 31 2.2k

Countries citing papers authored by Jaya Goyal

Since Specialization
Citations

This map shows the geographic impact of Jaya Goyal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaya Goyal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaya Goyal more than expected).

Fields of papers citing papers by Jaya Goyal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jaya Goyal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaya Goyal. The network helps show where Jaya Goyal may publish in the future.

Co-authorship network of co-authors of Jaya Goyal

This figure shows the co-authorship network connecting the top 25 collaborators of Jaya Goyal. A scholar is included among the top collaborators of Jaya Goyal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jaya Goyal. Jaya Goyal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sweeney, Colin L., et al.. (2023). P25 Single- and repeat-dose nonclinical data for PGN-EDO51 demonstrate potential for the treatment of Duchenne muscular dystrophy (DMD). Neuromuscular Disorders. 33. S103–S103. 1 indexed citations
2.
Sweeney, Colin L., et al.. (2023). P27 Three novel enhanced delivery Oligonucleotide candidates for Duchenne muscular dystrophy mediate high levels of exon 53, 45, and 44 skipping. Neuromuscular Disorders. 33. S103–S104. 1 indexed citations
3.
Goyal, Jaya, Ashling Holland, BS Garg, et al.. (2023). P44 Phase 1 study of PGN-EDO51 demonstrates tolerability, delivery and high levels of exon skipping for treatment of Duchenne muscular dystrophy (DMD). Neuromuscular Disorders. 33. S69–S69. 2 indexed citations
4.
Dev, Sunipa, et al.. (2023). Building Stereotype Repositories with Complementary Approaches for Scale and Depth. 84–90. 4 indexed citations
5.
Larkindale, Jane, Michelle Mellion, Jaya Goyal, et al.. (2023). Positive results from a first-in-human study supporting continued development of PGN-EDO51 for the treatment of duchenne muscular dystrophy (DMD). Journal of the Neurological Sciences. 455. 121117–121117. 1 indexed citations
6.
Goyal, Jaya, et al.. (2022). Improvements to Hybridization-Ligation ELISA Methods to Overcome Bioanalytical Challenges Posed by Novel Oligonucleotide Therapeutics. Nucleic Acid Therapeutics. 32(4). 350–359. 8 indexed citations
7.
Svrzikapa, Nenad, Kenneth Longo, Nripesh Prasad, et al.. (2020). Investigational Assay for Haplotype Phasing of the Huntingtin Gene. Molecular Therapy — Methods & Clinical Development. 19. 162–173. 12 indexed citations
8.
Goyal, Jaya, et al.. (2019). Envelop Insulation for Energy Efficient Smart Buildings in India. International Journal of Innovative Technology and Exploring Engineering. 8(11S). 429–434. 1 indexed citations
9.
10.
Subramanyam, Meena & Jaya Goyal. (2016). Translational biomarkers: from discovery and development to clinical practice. Drug Discovery Today Technologies. 21-22. 3–10. 13 indexed citations
11.
Hu, Xiao, Ali Seddighzadeh, Ying Zhu, et al.. (2014). Pharmacokinetics, pharmacodynamics, and safety of peginterferon beta‐1a in subjects with normal or impaired renal function. The Journal of Clinical Pharmacology. 55(2). 179–188. 8 indexed citations
12.
Gorovits, Boris, et al.. (2014). Recommendations for the characterization of immunogenicity response to multiple domain biotherapeutics. Journal of Immunological Methods. 408. 1–12. 48 indexed citations
13.
Wadhwa, Meenu, Meena Subramanyam, Susan Goelz, et al.. (2013). Use of a Standardized MxA Protein Measurement-Based Assay for Validation of Assays for the Assessment of Neutralizing Antibodies Against Interferon-β. Journal of Interferon & Cytokine Research. 33(11). 660–671. 13 indexed citations
14.
Edwards, Keith R., Jaya Goyal, Tatiana Plavina, et al.. (2013). Feasibility of the Use of Combinatorial Chemokine Arrays to Study Blood and CSF in Multiple Sclerosis. PLoS ONE. 8(11). e81007–e81007. 32 indexed citations
15.
Li, Xue, Michele Fiscella, Manoj Rajadhyaksha, et al.. (2013). Pre-Existing Biotherapeutic-Reactive Antibodies: Survey Results Within the American Association of Pharmaceutical Scientists. The AAPS Journal. 15(3). 852–855. 34 indexed citations
16.
Powell, Jerry S., Neil C. Josephson, Doris Quon, et al.. (2012). Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patients. Blood. 119(13). 3031–3037. 171 indexed citations
17.
Horan, Gerald, Susan Wood, Victor Ona, et al.. (2007). Partial Inhibition of Integrin αvβ6 Prevents Pulmonary Fibrosis without Exacerbating Inflammation. American Journal of Respiratory and Critical Care Medicine. 177(1). 56–65. 331 indexed citations
18.
Dupont, Stefan A., et al.. (2002). Mechanisms for Regulation of Cellular Responsiveness to Human IFN- β 1a. Journal of Interferon & Cytokine Research. 22(4). 491–501. 38 indexed citations
19.
Kumar, Shailendra, Shalom Avraham, Ajit Bharti, et al.. (1999). Negative Regulation of PYK2/Related Adhesion Focal Tyrosine Kinase Signal Transduction by Hematopoietic Tyrosine Phosphatase SHPTP1. Journal of Biological Chemistry. 274(43). 30657–30663. 20 indexed citations
20.
Goyal, Jaya, Karen Smith, John M. Cowan, et al.. (1998). The role for NES1 serine protease as a novel tumor suppressor.. PubMed. 58(21). 4782–6. 149 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Monica Hermanson Breakdown of academic impact, for papers by Charles D. Bangs Breakdown of academic impact, for papers by Samantha J. Busfield Breakdown of academic impact, for papers by Charlotte Rorsman Breakdown of academic impact, for papers by D. Wade Clapp Breakdown of academic impact, for papers by Carol M. Sullivan Breakdown of academic impact, for papers by Lucia Zanetta Breakdown of academic impact, for papers by Karin Gustafsson Breakdown of academic impact, for papers by Lawrence E. Goldfinger Breakdown of academic impact, for papers by Abel Sánchez‐Aguilera
Rankless by CCL
2026